The interplay between ACSL4, FASN, and SCD underscores a coordinated lipid metabolism axis in BQ-driven breast cancer, with ACSL4 as the key effector of energy production, potentially supporting metastatic potential by providing energy for EMT and invasion. This evidence concerns the gene FASN and breast carcinoma.